title: Immunoglobulin E, a pathogenic factor in Plasmodium falciparum malaria.
abstract: Most children and adults living in areas where the endemicity of Plasmodium falciparum malaria is high have significantly elevated levels of both total immunoglobulin E (IgE) and IgE antimalarial antibodies in blood. This elevation is highest in patients with cerebral malaria, suggesting a pathogenic role for this immunoglobulin isotype. In this study, we show that IgE elevation may also be seen in severe malaria without cerebral involvement and parallels an elevation of tumor necrosis factor alpha (TNF). IgE-containing serum from malaria immune donors was added to tissue culture plates coated with rabbit anti-human IgE antibodies or with P. falciparum antigen. IgE-anti-IgE complexes as well as antigen-binding IgE antibodies induced TNF release from peripheral blood mononuclear cells (PBMC). Nonmalaria control sera with no IgE elevation induced significantly less of this cytokine, and the TNF-inducing capacity of malaria sera was also strongly reduced by passing them over anti-IgE Sepharose columns. The cells giving rise to TNF were adherent PBMC. The release of this cytokine probably reflects cross-linking of their low-affinity receptors for IgE (CD23) by IgE-containing immune complexes known to give rise to monocyte activation via the NO transduction pathway. In line with this, adherent monocytic cells exposed to IgE complexes displayed increased expression of CD23. As the malaria sera contained IgG anti-IgE antibodies, such complexes probably also play a role in the induction of TNF in vivo. Overproduction of TNF is considered a major pathogenic mechanism responsible for fever and tissue lesions in P. falciparum malaria. This overproduction is generally assumed to reflect a direct stimulation of effector cells by certain parasite-derived toxins. Our results suggest that IgE elevation constitutes yet another important mechanism involved in excessive TNF induction in this disease.
authors.affiliation: Department of Immunology, Stockholm University, Sweden. peter.perlmann@imm2.su.se
authors.forename: P
authors.initials: P
authors.lastname: Perlmann
authors.forename: H
authors.initials: H
authors.lastname: Perlmann
authors.forename: B W
authors.initials: BW
authors.lastname: Flyg
authors.forename: M
authors.initials: M
authors.lastname: Hagstedt
authors.forename: G
authors.initials: G
authors.lastname: Elghazali
authors.forename: S
authors.initials: S
authors.lastname: Worku
authors.forename: V
authors.initials: V
authors.lastname: Fernandez
authors.forename: A S
authors.initials: AS
authors.lastname: Rutta
authors.forename: M
authors.initials: M
authors.lastname: Troye-Blomberg
mesh_terms: D000328:Adult; D000349:Africa; D000913:Antibodies, Protozoan / Q000097:blood; D002648:Child; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood*; D007074:Immunoglobulin G / Q000097:blood; D007963:Leukocytes, Mononuclear / Q000378:metabolism*; D016779:Malaria, Cerebral / Q000209:etiology / Q000276:immunology; D016778:Malaria, Falciparum / Q000209:etiology* / Q000276:immunology; D017455:Receptors, IgE / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis*
chemical_list: D000913:Antibodies, Protozoan; D007074:Immunoglobulin G; D017455:Receptors, IgE; D014409:Tumor Necrosis Factor-alpha; D007073:Immunoglobulin E